{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:26:41Z","timestamp":1749324401013},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ogc.2013.02.007","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T11:51:49Z","timestamp":1366285909000},"page":"257-268","source":"Crossref","is-referenced-by-count":9,"title":["Screening Adolescents and Young Women"],"prefix":"10.1016","volume":"40","author":[{"given":"Lori A.","family":"Boardman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katina","family":"Robison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2013.02.007_bib1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/AOG.0b013e3181ac06e0","article-title":"ACOG Committee Opinion No. 436: evaluation and management of abnormal cervical cytology and histology in adolescents","volume":"113","author":"Committee on Adolescent Health Care","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/LGT.0b013e3181cec411","article-title":"Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women","volume":"14","author":"Moscicki","year":"2010","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendations statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2013.02.007_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice Bulletin Number 131: screening for cervical cancer","volume":"120","author":"Committee on Practice Bulletins-Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib6","doi-asserted-by":"crossref","first-page":"S1S27","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"Updated guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31826e4609","article-title":"Cervical carcinoma rates among young females in the United States","volume":"120","author":"Benard","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2013.02.007_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1471-0528.2011.02944.x","article-title":"The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis","volume":"118","author":"Bruinsma","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2013.02.007_bib10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/infdis\/jis398","article-title":"Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women","volume":"206","author":"Hwang","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ogc.2013.02.007_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/1055-9965.EPI-10-1108","article-title":"Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women","volume":"20","author":"Winer","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ogc.2013.02.007_bib16","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":"Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2013.02.007_bib17","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2013.02.007_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ogc.2013.02.007_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib20","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","article-title":"Regression of low-grade squamous intra-epithelial lesions in young women","volume":"364","author":"Moscicki","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ogc.2013.02.007_bib21","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2007.03.029","article-title":"Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes","volume":"197","author":"Moore","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jpag.2007.04.012","article-title":"Management of cervical intraepithelial neoplasia 2 in adolescents","volume":"20","author":"Fuchs","year":"2007","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0b013e3181fe777f","article-title":"Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women","volume":"116","author":"Moscicki","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib24","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2010.09.008","article-title":"Prevalence and patient characteristics associated with CIN 3 in adolescents","volume":"204","author":"Clements","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/LGT.0b013e3181b8b024","article-title":"Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24","volume":"14","author":"Moore","year":"2010","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3322\/canjclin.52.6.342","article-title":"American Cancer Society guidelines for the early detection of cervical cancer","volume":"52","author":"Saslow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ogc.2013.02.007_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/AOG.0b013e3181e3e719","article-title":"The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer","volume":"116","author":"Castle","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib28","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ogc.2013.02.007_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9378(99)70256-5","article-title":"Risk factors for rapid-onset cervical cancer","volume":"180","author":"Hildesheim","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-151-9-200911030-00005","article-title":"Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006-2007","volume":"151","author":"Yabroff","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib32","first-page":"1038","article-title":"Cervical cancer screening among women aged 18-30 years\u2013United States, 2000-2010","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2013.02.007_bib33","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","article-title":"Treatment for cervical intraepithelial neoplasia and risk of preterm delivery","volume":"291","author":"Sadler","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2013.02.007_bib34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.AOG.0000151991.09124.bb","article-title":"The effect of loop electrosurgical excision procedure on future pregnancy outcome","volume":"105","author":"Samson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/AOG.0b013e3181b052de","article-title":"Loop electrosurgical excision procedure and the risk of preterm birth","volume":"114","author":"Jakobsson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/AOG.0b013e3181bf1ef2","article-title":"Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery","volume":"114","author":"Noehr","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1471-0528.2011.03052.x","article-title":"Birth outcomes following treatment for precancerous changes to the cervix: a population-based record linkage study","volume":"119","author":"Reilly","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2013.02.007_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/01.AOG.0000157126.12678.a6","article-title":"Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents","volume":"105","author":"Boardman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.168.17.1881","article-title":"Trade-offs in cervical cancer prevention: balancing benefits and risks","volume":"168","author":"Stout","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib41","series-title":"Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force","author":"Kulasingam","year":"2011"},{"key":"10.1016\/j.ogc.2013.02.007_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2013.02.007_bib43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/jir342","article-title":"Human papillomavirus (HPV) 6, 11, 16 and 18 prevalence among females in the United States\u2013National Health and Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?","volume":"204","author":"Dunne","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/dc.22904","article-title":"The unsatisfactory ThinPrep Pap Test\u2122: analysis of technical aspects, most common causes, and recommendations for improvement","author":"Rosa","year":"2012","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ogc.2013.02.007_bib45","first-page":"376","article-title":"Does a water-based lubricant affect Pap smear and cervical microbiology results?","volume":"55","author":"Pawlik","year":"2009","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ogc.2013.02.007_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0b013e3182426275","article-title":"Effect of lubricating gel on patient comfort during vaginal speculum examination: a randomized controlled trial","volume":"119","author":"Hill","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2013.02.007_bib47","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archpedi.153.10.1046","article-title":"Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents","volume":"153","author":"Kahn","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/LGT.0b013e3181585b9b","article-title":"Cervical cytology specimen adequacy: updated patient management guidelines","volume":"12","author":"Davey","year":"2008","journal-title":"J\u00a0Low Genit Tract Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1503\/cmaj.101156","article-title":"Management of Papanicolaou test results that lack endocervical cells","volume":"183","author":"Elumir-Tanner","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ogc.2013.02.007_bib50","first-page":"671","article-title":"National and state vaccination coverage among adolescents aged 13-17 years\u2013United States, 2011","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ogc.2013.02.007_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series intitiation and completion, National Immunization Survey-Teen, 2008-2009","volume":"128","author":"Dorrell","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2013.02.007_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Munoz","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2013.02.007_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ogc.2013.02.007_bib54","article-title":"Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: cancer registry-based follow-up","author":"Rana","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2013.02.007_bib55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ogc.2013.02.007_bib56","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jnci\/djs395","article-title":"Population-level impact of the bivalent, quadrivalent and nonavalent human papillomavirus vaccines: a model-based analysis","volume":"104","author":"Van de Velde","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ogc.2013.02.007_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1469-0691.2012.03946.x","article-title":"Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges","volume":"18","author":"Poljak","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ogc.2013.02.007_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/pubmed\/fds040","article-title":"Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era","volume":"34","author":"de Blasio","year":"2012","journal-title":"J\u00a0Public Health (Oxf)"},{"key":"10.1016\/j.ogc.2013.02.007_bib59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3802\/jgo.2012.23.4.282","article-title":"New insights into cervical cancer screening","volume":"23","author":"Boone","year":"2012","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ogc.2013.02.007_bib60","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ogc.2013.02.007_bib61","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2005.01.056","article-title":"Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence","volume":"193","author":"Elfgren","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2013.02.007_bib62","article-title":"Issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2013.02.007_bib63","first-page":"37","article-title":"The Manitoba human papillomavirus vaccine surveillance and evaluation system","volume":"21","author":"Kliewer","year":"2010","journal-title":"Health Rep"},{"key":"10.1016\/j.ogc.2013.02.007_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10552-011-9877-6","article-title":"The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions","volume":"23","author":"Hariri","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ogc.2013.02.007_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.27608","article-title":"A\u00a0population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2013.02.007_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ogc.2013.02.007_bib67","doi-asserted-by":"crossref","first-page":"e49751","DOI":"10.1371\/journal.pone.0049751","article-title":"VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus","volume":"7","author":"Tumban","year":"2012","journal-title":"PLoS One"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854513000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854513000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T15:48:38Z","timestamp":1595692118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854513000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0889854513000235"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2013.02.007","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}